Amarin Corp. Plc

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
PTLAPortola Pharmaceuticals, Inc. -0.50%17.866.5%$164.24m
HZNPHorizon Therapeutics Plc -1.77%49.836.5%$143.76m
CTLTCatalent, Inc. -0.30%77.502.3%$138.62m
MYOKMyoKardia, Inc. 2.40%104.741.8%$133.48m
BHCBausch Health Cos., Inc. 6.01%19.590.0%$126.70m
VRXValeant Pharmaceuticals International, Inc. 5.96%19.5814.1%$115.21m
UTHRUnited Therapeutics Corp. 1.29%119.4714.3%$76.15m
ICPTIntercept Pharmaceuticals, Inc. 2.17%73.8316.8%$60.97m
JAZZJazz Pharmaceuticals Plc 0.06%119.392.4%$60.68m
GWPHGW Pharmaceuticals Plc 2.36%125.656.2%$57.31m
AMRNAmarin Corp. Plc -1.31%6.771.6%$57.23m
ARGXargenx SE 1.56%222.720.0%$53.72m
AXSMAxsome Therapeutics, Inc. -0.35%76.711.9%$50.50m
PRGOPerrigo Co. Plc 1.39%55.536.8%$46.39m
ICLRICON plc 1.43%170.854.3%$45.08m

Company Profile

Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.